Current update on borderline ovarian neoplasms

American Journal of Roentgenology

Volumn 194, Issue 2, 2010, Pages 330-336

  Lalwani, Neeraj ^a   Shanbhogue, Alampady K P ^a   Vikram, Raghunandan ^b   Nagar, Arpit ^c   Jagirdar, Jaishree ^a   Prasad, Srinivasa R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Borderline ovarian tumors; Imaging neoplasms; Ovarian cancer; Ovarian tumors of low malignant potential

Indexed keywords

B RAF KINASE; BETA CATENIN; BRCA1 PROTEIN; CYTOKERATIN; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADNEXA DISEASE; ALGORITHM; BORDERLINE OVARIAN NEOPLASM; BRENNER TUMOR; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOMA; CYTOGENETICS; ENDOMETRIOSIS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; LYMPHOMA; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

ALGORITHMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 76149126417     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3936     Document Type: Review

References (34)

1. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005; 123[suppl]:S13-S57
2. Taylor HC Jr. Malignant and semi malignant tumours of the ovary. Surg Gynecol 1929; 48:204-230
3. Silverberg S. Borderline ovarian tumors: consensus, controversy, and continuing challenges. Pathol Case Rev 2006; 11:9-17
4. Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 2009; 9:415-428
5. Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Oncol 2007; 25:2928-2937
6. deSouza NM, O'Neill R, McIndoe GA, Dina R, Soutter WP. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR 2005; 184:999-1003
7. Gershenson DM. Clinical management potential tumours of low malignancy. Best Pract Res Clin Obstet Gynaecol 2002; 16:513-527
8. Swanton A, Bankhead CR, Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol 2007; 135:3-7
9. Gotlieb WH, Chetrit A, Menczer J, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005; 97:780-783
10. Webb PM, Purdie DM, Grover S, Jordan S, Dick ML, Green AC. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol 2004; 92:232-239
11. Tavassoli FA, Devilee P. World Health Organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs. Lyon, France: IARC Press, 2003
12. Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 2006; 49:517-525
13. Kurman RJ, Shih IeM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; 27:151-160
14. Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164:1511-1518
15. Shih IeM, Kurman RJ. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 2005; 11:7273-7279
16. Sieben NL, Oosting J, Flanagan AM, et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J Clin Oncol 2005; 23:7257-7264
17. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990; 21:397-403
18. Fadare O. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int J Gynecol Cancer 2009; 19:103-108
19. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31:539-557
20. Bent CL, Sahdev A, Rockall AG, Singh N, Sohaib SA, Reznek RH. MRI appearances of borderline ovarian tumours. Clin Radiol 2009; 64:430-438
21. Ohta T, Ohmichi M, Hayasaka T, et al. Characteristic features of ovarian borderline tumors with invasive implant. Arch Gynecol Obstet 2005; 272:278-282
22. Wu TI, Lee CL, Wu MY, et al. Prognostic factors predicting recurrence in borderline ovarian tumors. Gynecol Oncol 2009; 114:237-241
23. Kataoka M, Togashi K, Koyama T, et al. MR imaging of müllerian mucinous borderline tumors arising from endometriotic cysts. J Comput Assist Tomogr 2002; 26:532-537
24. Prat J. Pathology of the ovary. Philadelphia, PA: Saunders, 2004
25. Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999; 85:905-911
26. Zanetta G, Rota S, Lissoni A, Meni A, Brancatelli G, Buda A. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol 2001; 81:63-66
27. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging: multivariate analysis. Radiology 2000; 214:39-46
28. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR 2003; 180:1297-1304
29. Tsili AC, Tsampoulas C, Charisiadi A, et al. Adnexal masses: accuracy of detection and differentiation with multidetector computed tomography. Gynecol Oncol 2008; 110:22-31
30. Bazot M, Nassar-Slaba J, Thomassin-Naggara I, Cortez A, Uzan S, Darai E. MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors: correlation with final histology. Eur Radiol 2006; 16:2687-2699
31. Thomassin-Naggara I, Bazot M, Darai E, Callard P, Thomassin J, Cuenod CA. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 2008; 248:148-159
32. Thomassin-Naggara I, Cuenod CA, Darai E, Marsault C, Bazot M. Dynamic contrast-enhanced MR imaging of ovarian neoplasms: current status and future perspectives. Magn Reson Imaging Clin N Am 2008; 16:661-672
33. Risum S, Hogdall C, Loft A, et al. The diagnostic value of PET/CT for primary ovarian cancer: a prospective study. Gynecol Oncol 2007; 105:145-149
34. Jung DC, Choi HJ, Ju W, Kim SC, Choi KG. Discordant MRI/FDG-PET imaging for the diagnosis of borderline ovarian tumors. Int J Gynecol Cancer 2008; 18:637-641